Učitavanje...
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7 [Image: see text]
BACKGROUND: Mutations in the postsynaptic adaptor protein Dok-7 underlie congenital myasthenic syndrome (CMS) with a characteristic limb girdle pattern of muscle weakness. Patients usually do not respond to or worsen with the standard CMS treatments: cholinesterase inhibitors and 3,4-diaminopyridine...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Academy of Neurology
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2875925/ https://ncbi.nlm.nih.gov/pubmed/20458068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181dd43bf |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|